首页> 外文会议>AIChE Annual Meeting >Liver Regenerative Medicine and In Vivo Molecular Imaging for the Study of In Vivo Liver Organogenesis, Liver Disease and Development of New Diagnostics and Therapeutics
【24h】

Liver Regenerative Medicine and In Vivo Molecular Imaging for the Study of In Vivo Liver Organogenesis, Liver Disease and Development of New Diagnostics and Therapeutics

机译:肝脏再生医学和体内分子成像在体内肝脏器官,肝病和新诊断和治疗中的研究

获取原文

摘要

The emerging field of liver (hepatic) regenerative medicine encompasses understanding hepatic stem cell biology, organogenesis, tissue regeneration, and tissue homeostasis for the study of liver disease and development of new diagnostic and therapeutic strategies. The liver, the largest internal organ in the body, performs critical metabolic, endocrine, and synthetic physiological functions. As such, it displays elaborate cellular phenotypes and intricate tissue architecture, including hexagonal, lobular structure, complex vascular spaces with specialized endothelial cells, tissue specific fibroblasts and macrophages, complex blood supply (hepatic artery and portal vein) and heterogeneous billiary duct cells which line billiary duct drainage systems. With respect to capacity for organ regeneration, the liver is unmatched. For example, preclinical, rodent studies have indicated acute hepatocellular loss results in compensatory replication of neighboring adult hepatocytes. In contrast, chronic hepatocellular injury, which often leads to end-stage disease, is compensated for by small, liver stem/progenitor cells lying at the junction of intrahepatic bile ducts and the Canals of Hering. Furthermore, circulating and immune cells, like bone marrow mononuclear cells, mesenchymal stem cells, and tissue macrophages, all have major roles in orchestrating repair in liver injury. These repair mechanisms have been translated to established treatments, like human liver transplantation, and promising therapies, such as human hepatocyte, human bone marrow-derived, and human liver stem/progenitor cell transplantation. However, current and new therapies require harvesting of human tissue, underlying mechanisms of tissue homeostasis remain elusive and hard to decipher in vitro, in animals and humans, and new approaches and techniques are needed answer critical scientific questions and take steps towards new diagnostics and therapeutics aimed towards regeneration.
机译:肝脏(肝脏)再生医学的新兴领域包括了解肝病和新诊断和治疗策略的研究肝脏干细胞生物学,组织发生,组织再生和组织稳态。肝脏是身体中最大的内器官,进行关键的代谢,内分泌和合成生理功能。因此,它显示精细的细胞表型和复杂的组织结构,包括六边形,小叶结构,具有专用内皮细胞,组织特异性成纤维细胞和巨噬细胞的复杂血管空间,复杂血液供应(肝动脉和门静脉)和异质楼管细胞楼管排水系统。关于器官再生能力,肝脏是无与伦比的。例如,临床前,啮齿动物的研究表明急性肝细胞损失导致邻近成人肝细胞的补偿复制。相比之下,慢性肝细胞损伤通常导致终级疾病,由肝脏胆管和静脉运河展示的小,肝茎/祖细胞来补偿。此外,循环和免疫细胞,如骨髓单核细胞,间充质干细胞和组织巨噬细胞,所有这些都具有在肝损伤修复修复方面具有重大作用。这些修复机制已被转化为已建立的治疗,如人肝移植,以及有前途的疗法,例如人肝细胞,人骨髓导出和人肝茎/祖细胞移植。然而,目前和新的疗法需要收获人体组织,组织稳态的潜在机制仍然难以捉摸,难以在体外破译,在动物和人类中,并且需要新的方法和技术来回答重要的科学问题,并采取新的诊断和治疗方法旨在进行再生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号